Association between Three Therapeutic Strategies and Clinical Outcomes of 2009 FIGO Stage IB2/IIA2 Cervical Cancer

Table 1

Patient characteristics.

Characteristics	PST n (%)	NAC + RS n (%)	CCRT n (%)
Age (years)
>45	54 (51.9)	27 (50.9)	34 (69.4)	0.090
≤45	50 (48.1)	26 (49.1)	15 (30.6)
Pretreatment hemoglobin
≥115 g/L	52 (50.0)	25 (47.2)	33 (67.3)	0.077
＜115 g/L	52 (50.0)	28 (52.8)	16 (32.7)
FIGO stage
IB2	70 (67.3)	33 (62.3)	23 (46.9)	0.054
IIA2	34 (32.7)	20 (37.7)	26 (53.1)
Differentiation degree
Grade 1	4 (3.8)	1 (1.9)	0 (0)	0.357
Grade 2	72 (69.2)	40 (75.5)	39 (79.6)
Grade 3	28 (27.0)	12 (22.6)	10 (20.4)
Histology type
SCC	82 (78.8)	47 (88.7)	45 (91.8)	0.072
Non-SCC	22 (21.2)	6 (11.3)	4 (8.2)
Tumor size
>4 cm	51 (49.0)	26 (49.1)	22 (44.9)	0.085
>5 cm	46 (44.2)	20 (37.7)	16 (32.7)
>6 cm	7 (6.8)	7 (13.2)	11 (22.4)